SCHEMBL9405352

SCHEMBL9405352

Clc1ccc(OCCC2CCN(CC3CC3)CC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.52
HRH3 Q9Y5N1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7326912 0.85 SIGMAR1 (0.52) SIGMAR1
SCHEMBL7364335 0.85 SIGMAR1 (0.71) SIGMAR1
SCHEMBL7321964 0.80 HRH3 (0.64) SIGMAR1HRH3
Hydrochloric Acid SCHEMBL27431543 0.79 SIGMAR1 (0.64) SIGMAR1HRH3
Oxalic Acid SCHEMBL7326226 0.79 DRD2 (0.54) SIGMAR1
Hydrochloric Acid SCHEMBL7355256 0.78 NFE2L2 (0.54) HRH3
SCHEMBL30674540 0.78 NFE2L2 (0.70) HRH3
SCHEMBL4326032 0.75 NPY1R (0.50) SIGMAR1
SCHEMBL11447680 0.75 LTA4H (0.48) HRH3
SCHEMBL13280221 0.75 KCNH2 (0.53) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0580776-A1 USE OF SIGMA RECEPTOR ANTAGONISTS TO ENHANCE THE EFFECTS OF ANTIPSYCHOTIC DRUGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-02-02 EP claimed
WO-1992018127-A1 USE OF SIGMA RECEPTOR ANTAGONISTS TO ENHANCE THE EFFECTS OF ANTIPSYCHOTIC DRUGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-10-29 WO claimed